ADGRG1 and leukemia: However, when tested in a multivariate analysis including cytogenetic risk, leukocyte counts, type of leukemia, and receipt of an allogeneic stem cell transplantation GPR56 expression did not remain significant (Supporting information, Table S5) probably to the rather low number of patients in our cohort as well as to its known correlation with adverse cytogenetic markers.9